Doral and depressed level of consciousness Patient Reports February 13, 2012

Doral Side Effects Report #4913506-3
Doral side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2006. Male patient, 81 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: bradykinesia, cheyne-stokes respiration, depressed level of consciousness, fall , hepatic congestion, hypometabolism, nasopharyngitis. Doral dosage: 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, ACETYLSALICYLIC ACID SRT, SELBEX, ARICEPT, EUGLUCON, NICERGOLINE. Patient was hospitalized and became disabled. Patient recovered.

Doral Side Effects Report #4970866-5
Doral side effect was reported by a Health Professional from JAPAN on Mar 27, 2006. Female patient, 73 years of age, was diagnosed with insomnia, ill-defined disorder and was treated with Doral. After drug was administered, patient experienced the following side effects: delirium, depressed level of consciousness. Doral dosage: unknown. During the same period patient was treated with PAXIL, LUVOX, LENDORMN. Patient was hospitalized. Patient recovered.

Doral Side Effects Report #4990882-7
Doral side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2006. Female patient, 73 years of age, was diagnosed with insomnia, depression  and was treated with Doral. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, delirium, depressed level of consciousness, disorientation, electroencephalogram abnormal, euphoric mood, mastitis, pleural effusion. Doral dosage: 15 MG (1 IN 1 D) ORAL. During the same period patient was treated with PAXIL, LUVOX, LENDORM. Patient was hospitalized. Patient recovered.

Doral Side Effects Report #4913090-4
Doral side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2006. Female patient, 69 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: depressed level of consciousness, disorientation, haemodialysis. Doral dosage: 15 MG, 1 IN 1 D , ORAL. During the same period patient was treated with LENDORM, ZANTAC, PREDNISOLONE, ALFACALCIDOL, BLOPRESS, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.


Doral Side Effects Report #4961237-6
Doral side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2006. Female patient, 69 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: depressed level of consciousness, disorientation. Doral dosage: 15 MG (1 IN 1 D), ORAL. During the same period patient was treated with LENDORM, ZANTAC, PREDONINE, ALFACALCIDOL, MECOBALAMIN, BLOPRESS, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Doral Side Effects Report #4563695-8
Doral side effect was reported by a Physician from on Jan 13, 2005. Male patient, 29 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: alcohol use, body temperature decreased, body temperature increased, depressed level of consciousness, emotional distress, insomnia, overdose, vomiting. Doral dosage: 75 MG + 600MG, PO. During the same period patient was treated with LEVOMEPROMAZINE MALEATE, VALPROATE, INSULIN. Patient was hospitalized. Patient recovered.

Doral Side Effects Report #4583546-5
Doral side effect was reported by a Physician from on Feb 02, 2005. Male patient, 29 years of age, was diagnosed with insomnia and was treated with Doral. After drug was administered, patient experienced the following side effects: abdominal discomfort, alcohol use, aspiration, body temperature fluctuation, depressed level of consciousness, emotional distress, iatrogenic injury, overdose, vomiting. Doral dosage: 75 MG QD, PO. During the same period patient was treated with LEVOMEPROMAZINE MALEATE, VALPROATE, INSULIN. Patient was hospitalized. Patient recovered.